Review of Cardiovascular Effects of ADHD Medications
Abstract
The prevalence of attention-deficit/hyperactivity disorder (ADHD) among adults is approximately 4.4%, and more than 1.5 million Americans are prescribed stimulants for the treatment of ADHD. Stimulants (such as methylphenidate and amphetamine compounds), along with the nonstimulant atomoxetine, are widely prescribed for ADHD, and more Americans are continuing to use these medications throughout their adult lives. Given the action of these drugs on the cardiovascular system, health care professionals have asked whether chronic use of these substances substantively increase the risk for cardiovascular disease (CVD). A comprehensive body of research suggests that this may not be the case. All adult patients should be monitored for changes in blood pressure and pulse during treatment with ADHD medications; furthermore, people at risk for CVD or with existing CVD should be evaluated at baseline in conjunction with appropriate medical personnel, and ongoing treatment should be collaborative with such medical colleagues. [ Psychiatr Ann. 2018;48(7):323–327.]
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These side effects are usually dose-dependent and manageable, but rare cardiovascular events necessitate risk stratification and ongoing monitoring, especially in patients with preexisting cardiac conditions.
“These effects are usually dose-dependent and manageable, but rare cardiovascular events necessitate risk stratification and ongoing monitoring, especially in patients with preexisting cardiac conditions [149].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [149]
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · see citing works
Self-citationFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · see citing works
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601 · see citing works
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000252676.46043.18 · Cited by 1,395 · cited 1× · see citing works
“18,19 The possibility of increased cardiovascular mortality secondary to medication use has led to a substantial body of research assessing the long-term cardiovascular outcomes in people treated for ADHD with medication.”
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062 · see citing works
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824 · see citing works
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790 · see citing works
Self-citationSolanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677 · see citing works
Kessler, R. C., Adler, L. A., Barkley, R., Biederman, J., Conners, C. K., Faraone, S. V., Greenhill, L. L., Jaeger, S., Secnik, K., Spencer, T., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.001 · Cited by 663 · see citing works
Self-citationPeripheral and central effects of circulating catecholamines
William Tank, A., & Lee Wong, D. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140007 · Cited by 387 · see citing works
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368 · see citing works
Principles and techniques of blood pressure measurement.
Pickering, T. (2002) · Cardiology Clinics · doi:10.1016/s0733-8651(01)00009-1 · Cited by 299 · see citing works
ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
Habel, L. A., Cooper, W. O., Sox, C. M., Chan, K. A., Fireman, B. H., Arbogast, P. G., Cheetham, T. C., Quinn, V. P., Dublin, S., Boudreau, D. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1830 · Cited by 297 · see citing works
Clinical Pharmacokinetics of Atomoxetine
Sauer, J., Ring, B. J., & Witcher, J. W. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544060-00002 · Cited by 249 · see citing works
Heart Rate as a Risk Factor for Cardiovascular Disease
Perret‐Guillaume, C., Joly, L., & Bénétos, A. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.003 · Cited by 223 · see citing works
The estimated prevalence and correlates of adult ADHD in a German community sample
de Zwaan, M., Gruß, B., Müller, A., Graap, H., Martin, A., Glaesmer, H., Hilbert, A., & Philipsen, A. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0211-9 · Cited by 212 · see citing works
Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands
Michielsen, M., Semeijn, E., Comijs, H. C., van de Ven, P., Beekman, A. T. F., Deeg, D. J. H., & Kooij, J. J. S. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.101196 · Cited by 181 · see citing works
Swanson, J. M., & Volkow, N. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00433-8 · Cited by 173 · see citing works
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173 · see citing works
Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
Perrin, J. M., Friedman, R. A., Knilans, T. K., the Black Box Working Group, & Surgery, T. S. O. C. A. C. (2008) · Pediatrics · doi:10.1542/peds.2008-1573 · Cited by 161 · see citing works
Spencer, T. J., Adler, L. A., McGough, J. J., Muniz, R., Jiang, H., & Pestreich, L. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.032 · Cited by 155 · see citing works
Self-citationWilens, T. E., Hammerness, P. G., Biederman, J., Kwon, A., Spencer, T. J., Clark, S., Scott, M., Podolski, A., Ditterline, J., Morris, M. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0215 · Cited by 149 · see citing works
Mick, E. O., McManus, D. D., & Goldberg, R. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.011 · Cited by 134 · see citing works
Patrick, K. S., & Markowitz, J. S. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199711/12)12:6 · Cited by 132 · see citing works
The Importance of Accurate Blood Pressure Measurement
Handler, J. (2009) · The Permanente Journal · doi:10.7812/tpp/09-054 · Cited by 125 · see citing works
Rösler, M., Fischer, R., Ammer, R., Ose, C., & Retz, W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0005-5 · Cited by 121 · see citing works
Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD
Adler, L. A., Spencer, T. J., Williams, D. W., Moore, R. J., & Michelson, D. (2008) · Journal of Attention Disorders · doi:10.1177/1087054708316250 · Cited by 89 · see citing works
Self-citationGibbins, C., & Weiss, M. D. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0055-1 · Cited by 82 · see citing works
Long-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in Adults With ADHD
Weisler, R. H., Biederman, J., Spencer, T. J., & Wilens, T. E. (2005) · CNS Spectrums · doi:10.1017/s109285290000242x · Cited by 68 · see citing works
Trends in Office-Based Treatment of Adults With Stimulants in the United States
Olfson, M., Blanco, C., Wang, S., & Greenhill, L. L. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07975 · Cited by 65 · see citing works
National Trends in ADHD Diagnosis and Treatment: Comparison of Youth and Adult Office-Based Visits
Oehrlein, E. M., Burcu, M., Safer, D. J., & ZITO, J. M. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500269 · Cited by 33 · see citing works
High-Normal Blood Pressure and the Risk of Cardiovascular Disease
Kokubo, Y., & Kamide, K. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0336 · Cited by 32 · see citing works
Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications
Hammerness, P. G., Surman, C. B. H., & Chilton, A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0213-3 · Cited by 24 · see citing works
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
Stockman, J. A. (2009) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)79016-x · Cited by 17 · see citing works
Aneroid sphygmomanometers are accurate in the hospital and clinic setting
Canzanello, V. J. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00754-8 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Li, L., Yao, H., Zhang, L., Garcia‐Argibay, M., Du Rietz, E., Brikell, I., Solmi, M., Cortese, S., Ramos‐Quiroga, J. A., Ribasés, M., et al. (2023) · JCPP Advances · doi:10.1002/jcv2.12158 · Cited by 55 · see citing works
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211020 · Cited by 15 · see citing works
“These effects are usually dose-dependent and manageable, but rare cardiovascular events necessitate risk stratification and ongoing monitoring, especially in patients with preexisting cardiac conditions [149].”
Avellaneda-Ojeda, A., Murtaza, S., Shah, A. A., & Moukaddam, N. (2018) · Psychiatric annals · doi:10.3928/00485713-20180719-02 · Cited by 2 · see citing works
- Authors
- Levin, C. J., Goodman, D. W., & Adler, L. A.
- Venue
- Psychiatric Annals
- Publisher
- SLACK, Inc.
- Published
- 2018-07
- Volume
- 48
- Issue
- 7
- Pages
- 323-327
- ISSN
- 0048-5713 (ISSN-L)
- 1938-2456
- OpenAlex
- W2822330628
- Cited by
- 3
- References
- 35
- Citations by year
- 2025: 1 · 2023: 1 · 2018: 1
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Annals (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Keywords
- attention deficit hyperactivity disorder, ADHD medication, cardiovascular effects, stimulants, methylphenidate, amphetamine, atomoxetine, cardiovascular risk, blood pressure, pulse rate monitoring, adult ADHD, drug safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
